Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors
Hand-out
Press Releases
March 17, 2025

Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors

FREDERICK, Md., March 17, 2025 /PRNewswire/ -- Theradaptive, a privately held, clinical-stage biologics company developing targeted protein therapeutics is pleased to announce the appointment of Jeffrey W. Dunn to its

bradford

The Bradford Era

Local & Social